Siba Jneid1,2, Hicham Jabbour3,4, Aline Hajj1,2, Antoine Sarkis4,5, Hady Licha6, Souheil Hallit2,7,8,9,10,11, Lydia Rabbaa Khabbaz1,2. 1. 1 Pharmacology, Clinical Pharmacy and Quality Control Laboratory, Faculty of Pharmacy, Saint-Joseph University of Beirut, Beirut, Lebanon. 2. 2 Faculty of Pharmacy, Saint-Joseph University of Beirut, Beirut, Lebanon. 3. 3 Anesthesia and Critical Care Department, Saint-Joseph University of Beirut, Beirut, Lebanon. 4. 4 Faculty of Medicine, Saint-Joseph University of Beirut, Beirut, Lebanon. 5. 5 Cardiology Department, Saint-Joseph University of Beirut, Beirut, Lebanon. 6. 6 Cardiology Department, Tennova Healthcare Hospital, Cleveland, TN, USA. 7. 7 Faculty of Pharmacy, Lebanese University, Beirut, Lebanon. 8. 8 Faculty of Medicine and Medical Sciences, Holy Spirit University, Kaslik, Lebanon. 9. 9 Research Department, Psychiatric Hospital of the Cross, Jal Eddib, Lebanon. 10. 10 U1219 BPH Bordeaux Population Health Research Center Inserm, Université de Bordeaux, France. 11. 11 INSPECT-LB: Institut National de Sante Publique, Epidemiologie Clinique et Toxicologie, Faculty of Public Health, Lebanese University, Beirut, Lebanon.
Abstract
OBJECTIVE: Patients with hypertension tend to have a lower health-related quality of life (HRQOL) compared to normotensive patients. This study's main objectives are to assess (1) HRQOL and factors that might impact it and (2) association between HRQOL and adherence to treatment, trust in physician, and treatment satisfaction among patients with hypertension. METHODS: A cross-sectional study enrolled 196 patients from medical-care offices in Beirut, North and South Lebanon. Eligible patients signed a consent form and were asked to complete the Trust in Physician Scale, World Health Organization Quality of Life-brief (WHOQOL-brief) questionnaire, and Treatment Satisfaction Questionnaire (TSQM 1.4) as well as questions assessing medication adherence. RESULTS: Better antihypertensive medication adherence was significantly and positively correlated with better HRQOL domains except general health where significance was not reached ( P = .089). Better adherence was also significantly related to better treatment satisfaction (side effects, convenience, and global satisfaction but not to effectiveness) and an increased trust in physicians ( P < .0001). Better treatment satisfaction (TSQM domains) was significantly and positively associated with a better overall HRQOL ( P ≤ .001). Increased trust in physician scores were significantly and positively correlated with a better psychological health, environment, and overall HRQOL domains ( P = .045, .005, and .006, respectively). Finally, TSQM effectiveness, convenience, and global satisfaction were significantly higher when trust in physician was greater ( P = .017, .035, and .002, respectively). CONCLUSION: The results of this study revealed an association between increased adherence to treatment, a higher global satisfaction, and an increased quality of life. An increased patient satisfaction with their antihypertensive treatment and trust in their physician were also correlated with a greater adherence to treatment.
OBJECTIVE:Patients with hypertension tend to have a lower health-related quality of life (HRQOL) compared to normotensive patients. This study's main objectives are to assess (1) HRQOL and factors that might impact it and (2) association between HRQOL and adherence to treatment, trust in physician, and treatment satisfaction among patients with hypertension. METHODS: A cross-sectional study enrolled 196 patients from medical-care offices in Beirut, North and South Lebanon. Eligible patients signed a consent form and were asked to complete the Trust in Physician Scale, World Health Organization Quality of Life-brief (WHOQOL-brief) questionnaire, and Treatment Satisfaction Questionnaire (TSQM 1.4) as well as questions assessing medication adherence. RESULTS: Better antihypertensive medication adherence was significantly and positively correlated with better HRQOL domains except general health where significance was not reached ( P = .089). Better adherence was also significantly related to better treatment satisfaction (side effects, convenience, and global satisfaction but not to effectiveness) and an increased trust in physicians ( P < .0001). Better treatment satisfaction (TSQM domains) was significantly and positively associated with a better overall HRQOL ( P ≤ .001). Increased trust in physician scores were significantly and positively correlated with a better psychological health, environment, and overall HRQOL domains ( P = .045, .005, and .006, respectively). Finally, TSQM effectiveness, convenience, and global satisfaction were significantly higher when trust in physician was greater ( P = .017, .035, and .002, respectively). CONCLUSION: The results of this study revealed an association between increased adherence to treatment, a higher global satisfaction, and an increased quality of life. An increased patient satisfaction with their antihypertensive treatment and trust in their physician were also correlated with a greater adherence to treatment.
Entities:
Keywords:
TSQM; WHOQOL-brief; antihypertensive; medication adherence; quality of life; treatment satisfaction; trust in physician
Authors: Amy F Ho; Yuan Zhou; Jessica J Kirby; Md Mamunur Rahman; Kathryn Tessitore; Yousef Abdel-Raziq; James P d'Etienne; Chet D Schrader; Hao Wang Journal: Open Access Emerg Med Date: 2021-11-19
Authors: Kyriakos Souliotis; Theodoros V Giannouchos; Chistina Golna; Evangelos Liberopoulos Journal: Qual Life Res Date: 2021-06-22 Impact factor: 3.440
Authors: Hanine Abbas; Mazen Kurdi; Frank de Vries; Hein A W van Onzenoort; Johanna H M Driessen; Myriam Watfa; Rita Karam Journal: Patient Prefer Adherence Date: 2020-04-01 Impact factor: 2.711
Authors: Erin Peacock; Cara Joyce; Leslie S Craig; Zachary Lenane; Elizabeth W Holt; Paul Muntner; Marie Krousel-Wood Journal: J Hypertens Date: 2021-01 Impact factor: 4.776